Effect of androgen deprivation therapy on the results of PET/CT with [18F]fluciclovine in patients with prostate cancer

被引:0
|
作者
Bach-Gansmo, T. [1 ]
Sletten, H. [2 ]
Smastuen, M. C. [2 ]
Londalen, A. M. [1 ]
Bogsrud, T. V. [1 ]
机构
[1] Oslo Univ Hosp, Oslo, Norway
[2] Oslo & Akershus Univ Coll, Oslo, Norway
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP295
引用
收藏
页码:S123 / S123
页数:1
相关论文
共 50 条
  • [1] Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
    Bach-Gansmo, Tore
    Korsan, Katrine
    Bogsrud, Trond Velde
    [J]. TOMOGRAPHY, 2022, 8 (03) : 1477 - 1484
  • [2] Effect of androgen-deprivation therapy on the results of PET/CT with 18F-fluciclovine in patients with biochemical recurrence of prostate cancer
    Bach-Gansmo, T.
    Korsan, K.
    Bogsrud, T. V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S602 - S602
  • [3] [18F]Fluciclovine-PET/MRI use in monitoring response to androgen deprivation therapy in men with prostate cancer following initial staging
    Galgano, Samuel Joseph
    McDonald, Andrew Michael
    Rais-Bahrami, Soroush
    Choudhary, Gagandeep
    Bhambhvani, Pradeep
    McConathy, Jonathan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] [18F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer
    Felix Dietlein
    Peter Mueller
    Carsten Kobe
    Heike Endepols
    Melanie Hohberg
    Boris D. Zlatopolskiy
    Philipp Krapf
    Axel Heidenreich
    Bernd Neumaier
    Alexander Drzezga
    Markus Dietlein
    [J]. Molecular Imaging and Biology, 2021, 23 : 277 - 286
  • [5] [18F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer
    Dietlein, Felix
    Mueller, Peter
    Kobe, Carsten
    Endepols, Heike
    Hohberg, Melanie
    Zlatopolskiy, Boris D.
    Krapf, Philipp
    Heidenreich, Axel
    Neumaier, Bernd
    Drzezga, Alexander
    Dietlein, Markus
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (02) : 277 - 286
  • [6] [18F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients
    Nappi, Anna Giulia
    Ferrari, Cristina
    Mammucci, Paolo
    Rubini, Dino
    Lavelli, Valentina
    Sardaro, Angela
    Pisani, Antonio Rosario
    Rubini, Giuseppe
    [J]. CANCERS, 2022, 14 (06)
  • [7] PSA-Stratified Performance of [18F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer Patients under Androgen Deprivation Therapy
    Harsini, Sara
    Wilson, Don
    Benard, Francois
    [J]. DIAGNOSTICS, 2022, 12 (09)
  • [8] [18F]-fluciclovine positivity rate is not affected by androgen deprivation therapy (ADT) in recurrent prostate cancer post-prostatectomy.
    Abiodun-Ojo, Olayinka
    Jani, Ashesh
    Akintayo, Akinyemi
    Alemozaffar, Mehrdad
    Akin-Akintayo, Oladunni
    Odewole, Oluwaseun
    Tade, Funmialyo
    Nieh, Peter
    Master, Viraj
    Patel, Pretesh
    Shelton, Joseph
    Kucuk, Omer
    Chen, Zhengjia
    Hershatter, Bruce
    Fielder, Bridget
    Halkar, Raghuveer
    Schuster, David
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [9] COMPARISON OF FLUCICLOVINE (18F) PET-CT AND MRI IN DETECTION OF RECURRENT PROSTATE CANCER
    Akin-Akintayo, Oladunni
    Tade, Funmilayo
    Mittal, Pardeep
    Moreno, Courtney
    Nieh, Peter
    Rossi, Peter
    Raghuveer, Halkar
    Fei, Baowei
    Goodman, Mark
    Schuster, David
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E222 - E223
  • [10] A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer
    Zanoni, Lucia
    Bossert, Irene
    Matti, Antonella
    Schiavina, Riccardo
    Pultrone, Cristian
    Fanti, Stefano
    Nanni, Cristina
    [J]. FUTURE ONCOLOGY, 2018, 14 (11) : 1101 - 1115